Investors Snag ALNY 8.7% Cheaper Than Its Secondary Stock Offering
January 22, 2015 at 10:02 AM EST
Looking back to 2 days ago, Alnylam Pharmaceuticals Inc (ALNY) priced a $4,736,842 secondary stock offering at $95 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time..